Imipramine (Tofranil) Mega Study
Contents
Imipramine (Tofranil)
Imipramine (Tofranil)

Related

A
Count
A
Treatments
A
Effects
A
User Variables 1
A
Measurements 17

Tags

Imipramine
Tofranil
Imipramine (Tofranil)

Treatment Effectiveness

User reported effectiveness ratings Imipramine (Tofranil) for various conditions.

Conditions Major Improvement Moderate Improvement Much Worse No Effect Worse Responses
Neuropathy 0% 0% 0% 100% 0% 1

Side Effects

User-reported side effects of Imipramine (Tofranil)

Side Effect Percent of Reports Imipramine (Tofranil)
Constipation 35%
Dry Mouth 65%
Blurred Vision 20%
Changes in Appetite or Weight 27%
Changes in Sex Drive or Ability 18%
Difficulty Urinating 12%
Drowsiness 45%
Excessive Sweating 34%
Excitement or Anxiety 26%
Frequent Urination 10%
Nightmares 12%
Skin More Sensitive to Sunlight Than Usual 20%
Weakness or Tiredness 44%
Nausea 19%

Below is the degree of change seen after Imipramine (Tofranil) is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.

Imipramine (Tofranil) Info

Property Value
Variable Name Imipramine (Tofranil)
Aggregation Method SUM
Analysis Performed At 2020-10-09
Duration of Action 21 days
Filling Value 0
Kurtosis 2.4823887170104
Mean 63.158 count
Median 0 count
Minimum Allowed Value 0 count
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 25
Number of Measurements 17
Number of Measurements (including those generated by tagged, joined, or child variables) 17
Public true
Onset Delay 30 minutes
Standard Deviation 82.760000233756
Unit Count
User Variables 1
Variable Category Treatments
Variable ID 93941
Variance 6849.2176386913